These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1204 related articles for article (PubMed ID: 33010357)

  • 41. β-Blockers in heart failure: benefits of β-blockers according to varying male proportions of study patients.
    He YM; Yang XJ; Zhao X; Cheng XJ; Xu HF; Qian YX; Li X
    Clin Cardiol; 2012 Aug; 35(8):505-11. PubMed ID: 22488122
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characteristics of treated hypertension in incident hemodialysis and peritoneal dialysis patients.
    Griffith TF; Chua BS; Allen AS; Klassen PS; Reddan DN; Szczech LA
    Am J Kidney Dis; 2003 Dec; 42(6):1260-9. PubMed ID: 14655199
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Importance of beta-blocker dose in prevention of ventricular tachyarrhythmias, heart failure hospitalizations, and death in primary prevention implantable cardioverter-defibrillator recipients: a Danish nationwide cohort study.
    Ruwald AC; Gislason GH; Vinther M; Johansen JB; Nielsen JC; Philbert BT; Torp-Pedersen C; Riahi S; Jøns C
    Europace; 2018 Sep; 20(FI2):f217-f224. PubMed ID: 29684191
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group.
    Hjalmarson A; Goldstein S; Fagerberg B; Wedel H; Waagstein F; Kjekshus J; Wikstrand J; El Allaf D; Vítovec J; Aldershvile J; Halinen M; Dietz R; Neuhaus KL; Jánosi A; Thorgeirsson G; Dunselman PH; Gullestad L; Kuch J; Herlitz J; Rickenbacher P; Ball S; Gottlieb S; Deedwania P
    JAMA; 2000 Mar; 283(10):1295-302. PubMed ID: 10714728
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A comparative analysis of the results from 4 trials of beta-blocker therapy for heart failure: BEST, CIBIS-II, MERIT-HF, and COPERNICUS.
    Domanski MJ; Krause-Steinrauf H; Massie BM; Deedwania P; Follmann D; Kovar D; Murray D; Oren R; Rosenberg Y; Young J; Zile M; Eichhorn E;
    J Card Fail; 2003 Oct; 9(5):354-63. PubMed ID: 14583895
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of β-blocker agents and mortality in maintenance hemodialysis patients: an international cohort study.
    Toye C; Sood MM; Mallick R; Akbari A; Bieber B; Karaboyas A; Guedes M; Hundemer GL
    Clin Kidney J; 2024 May; 17(5):sfae087. PubMed ID: 38887596
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The mortality benefit of carvedilol versus bisoprolol in patients with heart failure with reduced ejection fraction.
    Choi KH; Lee GY; Choi JO; Jeon ES; Lee HY; Lee SE; Kim JJ; Chae SC; Baek SH; Kang SM; Choi DJ; Yoo BS; Kim KH; Cho MC; Park HY; Oh BH
    Korean J Intern Med; 2019 Sep; 34(5):1030-1039. PubMed ID: 30317846
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association between resting heart rate, chronotropic index, and long-term outcomes in patients with heart failure receiving β-blocker therapy: data from the HF-ACTION trial.
    Dobre D; Zannad F; Keteyian SJ; Stevens SR; Rossignol P; Kitzman DW; Landzberg J; Howlett J; Kraus WE; Ellis SJ
    Eur Heart J; 2013 Aug; 34(29):2271-80. PubMed ID: 23315907
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy and safety of carvedilol in treatment of heart failure with chronic kidney disease: a meta-analysis of randomized trials.
    Wali RK; Iyengar M; Beck GJ; Chartyan DM; Chonchol M; Lukas MA; Cooper C; Himmelfarb J; Weir MR; Berl T; Henrich WL; Cheung AK
    Circ Heart Fail; 2011 Jan; 4(1):18-26. PubMed ID: 21036889
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risk of All-Cause Mortality in Diabetic Patients Taking β-Blockers.
    Tsujimoto T; Kajio H; Shapiro MF; Sugiyama T
    Mayo Clin Proc; 2018 Apr; 93(4):409-418. PubMed ID: 29545006
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Decreased Mortality With Beta-Blockers in Patients With Heart Failure and Coexisting Atrial Fibrillation: An AF-CHF Substudy.
    Cadrin-Tourigny J; Shohoudi A; Roy D; Talajic M; Tadros R; Mondésert B; Dyrda K; Rivard L; Andrade JG; Macle L; Guerra PG; Thibault B; Dubuc M; Khairy P
    JACC Heart Fail; 2017 Feb; 5(2):99-106. PubMed ID: 28089316
    [TBL] [Abstract][Full Text] [Related]  

  • 52. β-Blockers in Atrial Fibrillation Patients With or Without Heart Failure: Association With Mortality in a Nationwide Cohort Study.
    Nielsen PB; Larsen TB; Gorst-Rasmussen A; Skjøth F; Lip GY
    Circ Heart Fail; 2016 Feb; 9(2):e002597. PubMed ID: 26823497
    [TBL] [Abstract][Full Text] [Related]  

  • 53. β-Blockers for prevention of sudden cardiac death in patients on hemodialysis: a propensity score analysis of the HEMO Study.
    Tangri N; Shastri S; Tighiouart H; Beck GJ; Cheung AK; Eknoyan G; Sarnak MJ
    Am J Kidney Dis; 2011 Dec; 58(6):939-45. PubMed ID: 21872979
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparative effectiveness of different beta-adrenergic antagonists on mortality among adults with heart failure in clinical practice.
    Go AS; Yang J; Gurwitz JH; Hsu J; Lane K; Platt R
    Arch Intern Med; 2008 Dec; 168(22):2415-21. PubMed ID: 19064823
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Carvedilol versus controlled-release metoprolol for elderly veterans with heart failure.
    Rector TS; Anand IS; Nelson DB; Ensrud KE
    J Am Geriatr Soc; 2008 Jun; 56(6):1021-7. PubMed ID: 18384583
    [TBL] [Abstract][Full Text] [Related]  

  • 56. β-Blockers could improve the 28-day and 3-year survival of patients with end-stage renal disease: a retrospective cohort study.
    Dong H; Zhou L; Yang L; Lu H; Cao S; Song H; Fu S
    Int Urol Nephrol; 2023 Jun; 55(6):1597-1607. PubMed ID: 36719527
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Low Utilization of Beta-Blockers Among Medicare Beneficiaries Hospitalized for Heart Failure With Reduced Ejection Fraction.
    Loop MS; van Dyke MK; Chen L; Safford MM; Kilgore ML; Brown TM; Durant RW; Levitan EB
    J Card Fail; 2019 May; 25(5):343-351. PubMed ID: 30339796
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The association of beta-blocker use with mortality in elderly patients with congestive heart failure and advanced chronic kidney disease.
    Molnar AO; Petrcich W; Weir MA; Garg AX; Walsh M; Sood MM
    Nephrol Dial Transplant; 2020 May; 35(5):782-789. PubMed ID: 31495887
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association between use of β-blockers and outcomes in patients with heart failure and preserved ejection fraction.
    Lund LH; Benson L; Dahlström U; Edner M; Friberg L
    JAMA; 2014 Nov; 312(19):2008-18. PubMed ID: 25399276
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mortality, Hospitalization, and Technique Failure in Daily Home Hemodialysis and Matched Peritoneal Dialysis Patients: A Matched Cohort Study.
    Weinhandl ED; Gilbertson DT; Collins AJ
    Am J Kidney Dis; 2016 Jan; 67(1):98-110. PubMed ID: 26319755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 61.